Sign up to save your podcasts
Or
Share Adjuvant Therapy for Stage III Melanoma 2023: Impact of Vaccines & Neoadjuvant Therapy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Adjuvant Therapy for Stage III Melanoma 2023: Impact of Vaccines & Neoadjuvant Therapy
In this episode of SurgOnc Today®, Tina Hieken, MD, from the Mayo Clinic, in Rochester, Minnesota, interviews Jay Lee, MD, MHSc, from Duke University in Durham, North Carolina, and Julia Terhune, MD, from the University of Maryland in Baltimore, Maryland. They will discuss the current and evolving indications for adjuvant therapy in patients with stage III melanoma including vaccine trials.
View all episodes
By Society of Surgical Oncology
5
1111 ratings
In this episode of SurgOnc Today®, Tina Hieken, MD, from the Mayo Clinic, in Rochester, Minnesota, interviews Jay Lee, MD, MHSc, from Duke University in Durham, North Carolina, and Julia Terhune, MD, from the University of Maryland in Baltimore, Maryland. They will discuss the current and evolving indications for adjuvant therapy in patients with stage III melanoma including vaccine trials.
More shows like SurgOnc Today®
View all
Freakonomics Radio
32,126 Listeners
Planet Money
30,653 Listeners
NEJM This Week
321 Listeners
JAMA Clinical Reviews
495 Listeners
Behind The Knife: The Surgery Podcast
1,315 Listeners
Pod Save America
87,320 Listeners
White Coat Investor Podcast
2,439 Listeners
The Daily
112,584 Listeners
Pod Save the World
24,683 Listeners
Up First from NPR
56,436 Listeners
Worklife with Adam Grant
9,187 Listeners
The Happiness Lab with Dr. Laurie Santos
14,391 Listeners
The AHPBA Podcast
9 Listeners
Consider This from NPR
6,369 Listeners
Good Inside with Dr. Becky
4,542 Listeners